Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||Advanced Solid Tumor||not applicable||HGS1029||Phase I||Actionable||In a Phase I clinical trial, HGS1029 demonstrated safety and some preliminary efficacy in patients with advanced solid tumors (J Clin Oncol 29: 2011 (suppl; abstr 3008)).||detail...|
|PubMed Id||Reference Title||Details|
|Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of HGS1029, an inhibitor of apoptosis protein (IAP) inhibitor, in patients (Pts) with advanced solid tumors: Results of a phase I study.||Full reference...|